Type 1 diabetes, metabolic syndrome and cardiovascular risk.
about
A Systematic Review and Meta-Analysis of Outcomes for Type 1 Diabetes after Bariatric SurgeryHeart Disease and Stroke Statistics-2017 Update: A Report From the American Heart AssociationDiabetic Kidney Disease: A Syndrome Rather Than a Single Disease.Gender, alexithymia and physical inactivity associated with abdominal obesity in type 1 diabetes mellitus: a cross sectional study at a secondary care hospital diabetes clinicAltered CD161 bright CD8+ mucosal associated invariant T (MAIT)-like cell dynamics and increased differentiation states among juvenile type 1 diabetics.Increased expression of IL-18 in the serum and islets of type 1 diabetics.Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes--a protocol for a randomised, double-blind, placebo-controlled study: the Lira-1 study.Liraglutide for treating type 1 diabetes.Mitigating Meal-Related Glycemic Excursions in an Insulin-Sparing Manner During Closed-Loop Insulin Delivery: The Beneficial Effects of Adjunctive Pramlintide and LiraglutideThe evolving role of bariatric surgery in patients with type 1 diabetes and obesity.Novel Association Between the Reverse-Dipper Pattern of Ambulatory Blood Pressure Monitoring and Metabolic Syndrome in Men But Not in Women.Dual-hormone treatment with insulin and glucagon in patients with type 1 diabetes.Development of sotagliflozin, a dual sodium-dependent glucose transporter 1/2 inhibitor.Prevalence, Pathophysiology, and Management of Androgen Deficiency in Men with Metabolic Syndrome, Type 2 Diabetes Mellitus, or Both.Bariatric Surgery in Type 1 Diabetes Mellitus: A Systematic Review.Outcome of bariatric surgery in patients with type 1 diabetes mellitus: our experience and review of the literature.Mass Spectrometry-Based Proteomic Study Makes High-Density Lipoprotein a Biomarker for Atherosclerotic Vascular Disease.Hemostasis, endothelial stress, inflammation, and the metabolic syndrome.Relationship of Serum Fetuin A with Metabolic and Clinical Parameters in German Children and Adolescents with Type 1 Diabetes.Introduction to the special issue on dietary control of immunometabolism.Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes.Correlation Between Pigment Epithelium-Derived Factor (PEDF) level and Degree of Coronary Angiography and Severity of Coronary Artery Disease in a Chinese Population.
P2860
Q26744812-6EA0DE5A-32A9-4CA1-966C-4690DBB12E32Q30238784-B022BB66-8F87-434A-8EB6-3B040D4B3F18Q33583012-330B4237-4020-4602-90AD-7F8C64413937Q33755674-9561905B-5D9D-4AD6-8DAC-DC0BFB3CAF4BQ35018923-7B0C9FEE-8D84-4F71-87D3-4A9088D941F2Q35044541-B28996CD-51EB-46A3-A1A5-706CD2F4C6A9Q35331836-FE7754D7-1546-4E8B-A737-365814F19308Q35939660-A2E9E481-49BF-4F82-BC2D-35DE604DD68AQ37025563-02598EC8-96D7-4A45-B1BF-CA7C27A5821CQ37074338-A01582D7-2A44-4D8E-B1D7-62085183C16DQ37328659-DB9B10D2-AC51-4D90-B941-305F30322B86Q38297682-B0C4CBB0-3AAE-4886-8D1C-4E0921067E44Q38358921-52B3099B-523F-4523-BC88-3A4491D86826Q38569696-D4A6A4F7-FD61-43D1-9796-9A175AA03A04Q38603222-193BC983-AF32-463E-B15E-8BF9F266B9C5Q38820439-CFC707EB-D9F3-44F2-95A9-290695F5F5B6Q41908048-33B5CA84-88C3-4307-8C41-FD354782A6B6Q46247156-29F6DED4-7CF0-43F3-B090-13B21737D9BCQ47365110-8FFF0283-72D7-418F-A1F9-1879156F62D2Q48149982-27DE9944-1AB7-4BF8-A06B-77C4D73FBC60Q48206358-2F03B29B-6FAD-448B-8069-76BA6650C4D3Q54940550-075CF19B-8377-4E80-86E3-93F857EBD03E
P2860
Type 1 diabetes, metabolic syndrome and cardiovascular risk.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Type 1 diabetes, metabolic syndrome and cardiovascular risk.
@en
type
label
Type 1 diabetes, metabolic syndrome and cardiovascular risk.
@en
prefLabel
Type 1 diabetes, metabolic syndrome and cardiovascular risk.
@en
P1433
P1476
Type 1 diabetes, metabolic syndrome and cardiovascular risk.
@en
P2093
Juan Pedro-Botet
Juana A Flores Le-Roux
P304
P356
10.1016/J.METABOL.2013.10.002
P577
2013-10-24T00:00:00Z